HEALTHNYT US
With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Access
Merck is taking steps to ensure access to a new H.I.V. prevention pill. Health workers at the University of Zambia in Lusaka are engaging students about H.I.V. prevention drugs.
Mentioned
Related Signal
Adjacent reporting
- STAT+: Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pill
- FDA approves cholesterol pill from Merck
- At last, a pill that can prevent COVID after exposure to infected people
- CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans
- Lilly’s GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans